Berkshire profit rises, cash soars to record

Berkshire Hathaway reported a 34% rise in Q3 operating profit to $13.49 billion and a 17% increase in net income to $30.8 billion, primarily due to lower insurance losses, though revenue growth was a modest 2%. The conglomerate maintained a cautious market stance, allowing cash to swell to a record $381.7 billion while net selling stocks for the 12th consecutive quarter and halting share buybacks. This conservatism, coupled with economic uncertainty impacting various subsidiaries, has led to Berkshire's stock significantly underperforming the broader market, raising investor impatience ahead of Greg Abel's succession as CEO from Warren Buffett, who will remain chairman.

Analysis

Berkshire Hathaway reported a 34% increase in third-quarter operating profit to $13.49 billion, surpassing analyst forecasts, primarily due to lower insurance losses. Net income also grew 17% to $30.8 billion. However, revenue growth was a modest 2%, lagging the overall U.S. economy, with key segments like Duracell and Fruit of the Loom experiencing reduced sales due to economic uncertainty and waning consumer confidence.

The conglomerate's cash reserves swelled to a record $381.7 billion, reflecting a continued cautious market stance, as it sold more stocks than it bought for the 12th consecutive quarter and halted share buybacks for five quarters. This conservative capital deployment, despite the stock significantly lagging the broader market, has led to investor apprehension and a 12% stock decline since the announcement of Warren Buffett's succession.

The impending CEO transition to Greg Abel, who will take over from Warren Buffett at year-end, introduces uncertainty regarding the deployment of the massive cash pile. While the company plans a $9.7 billion acquisition of OxyChem, this represents a small fraction of the available cash. Analysts note that Abel, known as a more hands-on manager, has a significant opportunity to deploy capital, potentially within Berkshire's operating businesses or through a dividend, which has not occurred since 1967.

Investor sentiment is currently bearish, with the stock trailing the S&P 500 by 32 percentage points since Buffett's succession announcement. The market seeks a clear catalyst for growth, given the underperformance of several operating units and the lack of significant capital deployment beyond the OxyChem deal. The long-term value proposition remains, but short-term impatience is evident.

Key Decisions for Investors

• Monitor Greg Abel's initial capital allocation strategies and any shifts in Berkshire's conservative investment approach, particularly regarding the record cash reserves.
• Evaluate the performance trends of Berkshire's diverse operating businesses for signs of improved revenue growth or strategic investments that could act as catalysts.
• Consider the long-term value proposition of Berkshire Hathaway against its recent market underperformance and the potential for a more active capital deployment strategy under new leadership.